- Savara (NASDAQ:SVRA) appoints Badrul Chowdhury, M.D., Ph.D., to the newly created position of Chief Medical Officer, effective immediately.
- Dr. Chowdhury joins Savara from AstraZeneca (AZN), where he was Senior VP, Chief Physician-Scientist for Respiratory, Inflammation, and Autoimmunity Late Stage Development, in Biopharmaceuticals R&D.